The RDCRN program is designed to advance medical research on rare diseases by providing support for clinical studies and facilitating collaboration, study enrollment and data sharing. Through the RDCRN consortia, physician scientists and their multidisciplinary teams work together with patient advocacy groups to study more than 200 rare diseases at sites across the nation.
-
Research
-
- Funding & Notices
-
- News & Media
- About Translation
-
- About NCATS
-
NCATS Programs & Initiatives
- 3-D Tissue Bioprinting Program
- Stem Cell Translation Laboratory
- Assay Development and Screening Technology (ADST)
- Biomedical Data Translator
- Bridging Interventional Development Gaps (BrIDGs)
- Chemistry Technology
- Discovering New Therapeutic Uses for Existing Molecules
- Genetic and Rare Diseases Information Center (GARD)
- Matrix Combination Screening
- Early Translation Branch (ETB)
- A Specialized Platform for Innovative Research Exploration (ASPIRE)
- A Translational Approach to Addressing COVID-19
- Antiviral Program for Pandemics
- Clinical Trial Readiness for Rare Diseases, Disorders and Syndromes
- Multidisciplinary Machine-Assisted, Genomic Analysis and Clinical Approaches to Shortening the Rare Diseases Diagnostic Odyssey
- National COVID Cohort Collaborative (N3C)
- The Accelerating Medicines Partnership® Bespoke Gene Therapy Consortium (BGTC)
- NIH Common Fund Programs
- Rare Diseases Registry Program (RaDaR)
- Tissue Chip for Drug Screening
- Toxicology in the 21st Century (Tox21)
- Functional Genomics Lab
- Therapeutics for Rare and Neglected Diseases (TRND)
- About NCATS
- Home
- Research
- Rare Diseases Research and Resources
- Rare Diseases Clinical Research Network (RDCRN)
Rare Diseases Clinical Research Network (RDCRN)
Watch the New I Am Translational Science Video with Mustafa Sahin
Child neurologist Mustafa Sahin, M.D., Ph.D., shares how advances in translation helped his team provide new treatments to young patients with rare neurodevelopmental disorders.
About the RDCRNLearn more about the RDCRN program and its network of study sites.
RDCRN Funding InformationFind out about funding opportunities, how to apply and how to collaborate.
Current RDCRN ConsortiaDiscover the 20 consortia and their central data management and coordinating center.
Rare Diseases Health InformationAccess information about rare diseases for patients and researchers.
Learn more about the RDCRN program and its network of study sites.
Find out about funding opportunities, how to apply and how to collaborate.
Discover the 20 consortia and their central data management and coordinating center.
Rare Diseases Health Information
Access information about rare diseases for patients and researchers.
Work with Us
Learn about the RDCRN
The RDCRN program is designed to advance medical research on rare diseases by providing support for clinical studies and facilitating collaboration, study enrollment and data sharing. Through the RDCRN consortia, physician scientists and their multi-disciplinary teams work together with patient advocacy groups to study more than 200 rare diseases at sites across the nation.
NCATS Programs & Initiatives
- News & Media
- Funding & Notices
-